arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Bausch & Lomb Corp

BLCO
$16.75 ▲ +0.41 (+2.51%) at close
Industrials ·Ophthalmic Goods ·USOphthalmic Goods
24 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
34
Health
Poor
Bearish
auto_awesome

Analytical Summary

Bausch & Lomb Corp faces fundamental challenges with weakness in Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $6.0B
Dividend Yield
Revenue Growth 9.1%
Op. Margin 6.0%
ROIC 0.7%
FCF / Share $0.23
Trailing P/E
Price / Book 0.9x
FCF Yield 1.4%
Debt / Equity 0.80
info Valuation on last close. End-of-day price, Aug 7, 2026.

24-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.39B
↑ +9.1%
Net Income Profit after all expenses
$-14.00M
↑ +77.4%
Operating Margin Operating profit as % of sales
6.0%
↑ +124.5% 34th
FCF / Share Free cash flow per share
$0.23
↑ +219.9%
Long-Term Debt Long-term obligations
$5.08B
↑ +0.8%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
25
Returns
38
Financial Health
43
Cash Quality
29

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 24 quarters